Drug Firm Lupin received USFDA approval to market HIV drug Prezista tablets

Dec 31, 2014 16:37 IST

Drug firm Lupin on 30 December 2014 received the approval from the United States Food and Drugs Administration (USFDA) to market its generic drug Prezista tablets in the US. The tablets with chemical name Darunavir Ethanolate will be used to treat HIV-1 infection.

Earlier, the company had also received USFDA approval to market a generic version of ViiV Healthcare’s Epivir Tablets, used in treating HIV infection, in the American market.

About Lupin

The company is headquartered in Mumbai, India. Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations for the developed and developing markets of the world.

Is this article important for exams ? Yes69 People Agreed
Read more Current Affairs on: USFDA , Drug Firm Lupin , HIV drug

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK